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ABSTRACT
RETINAL STEM CELL CULTURE ON PLANAR SCAFFOLD FOR
TRANSPLANTATION IN ANIMAL MODELS OF RETINAL DEGENERATION
Tina Xia, Deepti Singh, Shaobin Wang, Scott Ketner, Ron Adelman, Lawrence Rizzolo.
Department of Ophthalmology and Department of Surgery-gross anatomy, Yale
University School of Medicine, New Haven, CT.
Successful differentiation of pluripotent stem cells into retinal cells and subsequent
transplantation in animal models have made stem cell-based therapy a closer possibility for
treating retinal degenerations. However, major limitations are low efficiency in deriving
desired cell types and continued need for large animal studies to validate small animal
studies. In this study, we modified a biopolymer scaffold with laminin-521 as a novel
substrate to culture retinal progenitor cells (RPCs). We hypothesize that laminin-521 will
increase cell retention and provide a developmental signal for RPCs to mature and selforganize. The RPC scaffold culture was transplanted into a RD10 mice, a rodent model of
retinal degeneration to evaluate the effects on disease pathology, and into pig eyes for a
large animal pilot transplantation study. Differentiation of RPC was monitored by qRTPCR, immunofluorescence and immunoblotting. Graft survival, integration, and host
immune reactivity was assessed via histology and immunofluorescence. The laminin-521
coated scaffold (GCH-L521) increased cell attachment compared to non-coated scaffold.
GCH-L521 was able to support growth and continued differentiation of RPC. When
transplanted into animal models, the RPC scaffold graft survived in the host and did not
cause significant host immune reaction. In RD10 mice, transplantation resulted in
improved photoreceptor preservation. GCH-L521 can serve as a new substrate to culture
RPC and simultaneously functions as a transplantation vehicle that is well-tolerated in the
host.
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INTRODUCTION
Pluripotent stem cells, such as embryonic stem cells (ESC) and induced pluripotent stem
cells (iPSC), are promising tools for regenerative medicine and transplantation. There is
growing research on stem cell therapy in neurodegenerative diseases, including
Alzheimer’s, amyotrophic lateral sclerosis, and retinal degeneration [2-4]. Retinal tissue
has been differentiated successfully from stem cells and demonstrated positive efficacy
results when transplanted into rodent models. However, efficient cell cultures that produce
transplantable tissue with long-term treatment efficacy remain a challenge.
The Retina and Retinal Degeneration
The retina is the neurosensory tissue that lines the inside of the eye; it processes and
conveys light signals to the brain. An integral part of the retina is the retinal pigment
epithelium (RPE), which forms the outer brain-retinal barrier and regulates ion and
nutrition balance and waste removal from the retina [5]. The retina contains intricately
connected layers of specialized neurons, all functioning to transduce electrical signal from
the photoreceptors to the ganglion cells and to the CNS (Figure 1).
Retinal degeneration describes the death of retinal cells from a variety of causes,
leading to vision loss and reduced functionality for the patients. Two common forms of
retinal degeneration are retinitis pigmentosa (RP) and age-related macular degeneration
(AMD). RP is a heterogeneous disease caused by a number of genetic mutations affecting
photoreceptor function, leading to degeneration [6]. The etiology of AMD is complex and
likely a combination of genetic and environmental factors, and its pathology is thought to
begin with degeneration of either the RPE or the photoreceptors [7]. Additionally, AMD is
currently the leading cause of blindness in the elderly population of developed countries,
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with 2 million people affected in the United States [8]. With the aging population, the
prevalence in the US is projected to increase two-fold by 2020. From a public health
perspective, this will be a significant increase in the burden of disease.
ILM
Ganglion cells

Inner nuclear
layer

Photoreceptor
RPE

Figure 1. Eye anatomy and retinal layers. Histology of retina. Schematic diagram
copied with permission from Kimbrel and Lanza, 2015 [1]. Histology photo
adapted from Junqueira’s Basic Histology: Text and Atlas, 12th Edition.
Currently, treatments of AMD work to prevent progression of disease or to address
the signs and complications of disease. In early stages of AMD, AREDS vitamins
consisting of vitamin E, vitamin C, copper, zinc, lutein, and zeaxanthin, can be taken to
retard progression to advanced disease characterized by abnormal neovascularization, but
the efficacy is low [9]. The mainstay of treatment for advanced AMD involve laser
procedures and intraocular anti-VEGF injections to prevent worsening pathology. For RP,
there is currently no widespread, effective therapy. However, active research is looking
into neuroprotective drugs, gene therapy and vision prosthesis for the disease [6]. Stem cell
therapy is also under active investigation for AMD, RP and other retinal disease; this
modality is aimed at replacing the deteriorating tissue of the retina to regain visual function.
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Stem Cells Therapy for Retinal Diseases
Stem cells have therapeutic potential due to their pluripotency state. Pluripotent cells can
self-renew and differentiate into many different types of tissue; therefore, stem cells are a
potential source of unlimited tissue for research and treatment. The embryonic stem cell
(ESC) and induced pluripotent stem cell (iPSC) are pluripotent cells most commonly used
to generate differentiated tissue. iPSCs are adult cells that have been reprogrammed back
to a pluripotent state through the introduction of four transcription factors Oct3/4, Sox2,
Klf4, and c-Myc, a method first described by Dr. Yamanaka in 2006 [10, 11]. Many types
of specialized tissue cells are able to be differentiated from pluripotent stem cells, including
retinal cells, pancreatic islet cells, hepatocytes, and neural progenitor cells, to name a few
[12-14]. In order for stem cells to be therapeutic, the differentiated tissue must resemble
native tissue in structure and function, and can survive and contribute to function within
the host.
Retinal cells have been successfully differentiated from stem cells. RPE derived
from ESC and iPSC exhibited similar pigmentation, morphology and gene expression as
primary human fetal RPE [15-17]. With the appropriate culture conditions, stem cellderived RPE also developed the expected RPE functions, such as maintaining
transepithelial resistance (TER) as an epithelium and phagocytosis of photoreceptor outer
segments for waste removal [17-19]. Because RPE consists of one cell type, it is easier to
differentiate to yield consistent, uniform cultures compared to differentiating the neural
retina which contains many different types of retinal neurons. In part, due to this reason,
stem-cell derived RPE has been more extensively studied than retinal progenitor cells
(RPCs), with more data from both animal studies and patient clinical trials.
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However, in many retinal diseases including advanced AMD, the neural retina
becomes damaged. Transplanting new RPE may better support the host retina but it
ultimately does not replace the degenerating photoreceptors and other retinal neurons. To
address this challenge, RPCs also have been differentiated from stem cells with the goal of
recapitulating retinal development to produce the different neural retinal cells. Notably, 3D
retinal organoids that resemble optic vesicles in early eye organogenesis have been cultured
from stem cells using several approaches [20-24]. With time, these retinal organoids
develop into retinal cups (RC) and acquired laminations containing cells that express
markers for differentiating photoreceptor, amacrine, horizontal and ganglion cells. One
group supported RC cultures for 27 weeks and demonstrated the formation of
photoreceptor outer segment, a morphologic feature characteristic of photoreceptors and
indicated maturation of these neurosensory cells [25]. A small number of these
photoreceptors even exhibited electrical signal in response to a light stimulus measured via
patch clamp; this encouraging result suggested some degree of functional maturation as
well.
The long culture times and an ongoing need to generate mature functional retinal
cells from RPCs remain major challenges to translating stem cell-derived retinal cups into
treatments for patients. Many improvements have been made in the differentiation
protocols for deriving RPE and RPC from stem cells. For example, RPE cultures can be
enriched by supplementing ESCs with nicotinamide and activin A and Wnt and Nodal
antagonists [19, 21, 26]. The substrates on which retinal cells attach and grow also play a
critical role in the maturation process in culture. It has been shown that growing RPE cells
on a porous mesh surface, such as poly(l-lactide-co-ε-caprolactone) and parylene-C coated
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with extracellular matrix, resulted in more functionally and morphologically mature cells
[27-29]. These studies demonstrated the importance of understanding the cellular niche
conditions for growing and differentiating retinal cells. There is concurrent research in
substrates and matrices that can facilitate maturation of RPC.
Scaffolds and Laminin Proteins in Retinal Culture
Early studies transplanting retinal cups containing RPCs or purified photoreceptor
precursors in rodent models yielded promising results for cell engraftment with some
functional improvement. However, the limitations were the low efficiency of cell survival
and integration in the host retina [30, 31]. An additional limitation of using retinal cups for
transplantation is the spherical shape of the organoids, which prevented the RPCs from
laying as a flat sheet when implanted underneath the host retina. Investigators attempted to
overcome this latter limitation by cutting retinal cups in half to decrease the degree of
curvature [32]. However, control of retinal cup orientation was still challenging, as some
cells reformed its more spherical shape.
Three-dimensional scaffolds are being studied as a substrate for culturing RPC and
as a vehicle for transplantation. Planar scaffolds can aid RPCs to grow in an organized flat
conformation, which is easier to insert for subretinal transplantations. Additionally,
scaffolds can support more RPC cells because they provide ample surface area for more
cells to attach and proliferate [33, 34]. Some studies have shown that the mechanical
properties of the scaffolds, such as stiffness and surface topography, can improve retinal
differentiation. For example, polycaprolactone (PCL) scaffold etched with linear ridges
and grooves promoted RPC proliferation and subsequent photoreceptor differentiation [35].
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Previous work from Dr. Lawrence Rizzolo’s lab synthesized and characterized a
novel 3-D scaffold for culturing RPC. The scaffold has a porous structure due to the
lyophilization process and is composed of gelatin, chondroitin-sulfate, and hyaluronic acid,
termed the GCH scaffold (Figure 2A). Larger scaffold blocks were sectioned into 60µm
thick discs and RPCs were seeded onto the scaffold (Figure 2B). Previous results showed
that GCH scaffold supported faster RPC differentiation from human ESC [36].
Additionally, RPC cultured on GCH had greater expression of markers for various
differentiating neurons within the retina compared to RPC cultured on 2-D commercially
available culture substrate. This project aimed to investigate a further modification of the
GCH scaffold to improve the efficiency of RPC cultures. Laminin-521, an extracellular
protein, was used to coat GCH scaffold before culturing RPCs.
To promote cell attachment in cultures, scaffolds can be coated with extracellular
matrix proteins such as collagen, fibronectin and laminin. Laminin proteins are found
abundantly in the extracellular matrix of tissues. Laminins have a heterotrimeric structure
comprised of an α chain, a β chain, and a γ chain, with each chain type having several
isoforms. In addition to increasing cell attachment, laminins play important roles in
directing polarized cell migration and retinal cellular function during the early development
of the distinct retinal layers [37, 38]. Disruption of β2 chain, for example, can lead to
abnormal photoreceptor morphology and loss synaptic formation [39].
The laminin-521 used in this project is composed of α5, β2, and γ1 chains. We
chose to coat the GCH scaffold with laminin-521 because and is the most abundant laminin
in the internal limiting membrane (ILM) [40]. The ILM functions as a basement membrane
separating the inner retina from the vitreous (Figure 1). As a basement membrane, it
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provides a platform for cell attachment and cell compartmentalization. But the ILM also
may function to maintain retinal polarity and ganglion cell organization. When the ILM is
interrupted, there is significant loss of adjacent ganglion cells, disorganization of the
ganglion cell layer, as well as retraction of neuron processes [41, 42]. These studies suggest
that the ILM has a role in retinal cell differentiation and survival. Laminin-521 may be a
crucial extracellular protein of the ILM in directing cell attachment and retinal polarity.

A

B

C

Retinal Cups

Scaffold in
well
Figure 2. GCH scaffold and culture model. A) scan electron microscopy of
scaffold; image provided by Dr. Deepti Singh. B) thicker section of scaffold, to
be sectioned into 60µm thickness C) RC containing RPC are seeded onto GCH
scaffold in media.

Retinal Transplantation Studies
A major goal of tissue engineering is to obtain a transplantable graft capable of replacing
diseased tissue. Transplantation of stem cell-derived RPE and RPC have been studied in
animal models, and clinical trials in humans are ongoing. Early transplantation studies were
carried out in animal models of retinal degeneration such as the Royal College of Surgeon
(RCS) rats, which has a mutation in MERTK and models retinitis pigmentosa [43]. ESC
and iPSC-derived RPE transplanted in these rodent models resulted in less photoreceptor
degeneration when compared to non-transplanted eyes [43-46]. Transplanted eyes also
exhibited better visual function when measured with electroretinogram (ERG) or
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optokinetic testing [45, 46]. These results highlighted the potential efficacy of RPE
transplantation, but the challenges were how to maintain survival of transplanted cells and
the functional improvement for the long-term.
In addition to RPE, transplantation of stem cell-derived RPC into animal models
have also been investigated and demonstrated integration of RPCs with the host retina.
RPCs migrated into the retinal layers and some cells formed synaptic connections with host
retinal cells [31, 32, 47, 48]. On functional testing, transplanted eyes performed better than
control eyes. As previously discussed, the culture conditions, such as substrates and trophic
supplements, can affect the differentiation of RPC in significant ways. Qu et al. found that
the length of time RPCs are cultured in suspension before being seeded onto a flat surface
influenced whether the RPCs contained more retinal glial cells or neuronal cells [47]. When
left in suspension culture longer, RPCs contained more neuronal cells and when
transplanted in RCS rats resulted in better ERG signals than animals transplanted with
RPCs that were differentiated for a shorter period of time in suspension. Ongoing research
continues to investigate these nuances of the culture microenvironment in order to improve
differentiation methods and achieve more mature and functional RPCs.
Despite the challenges of translating stem cell therapy to humans, RPE
transplantation are being studied in patients. A phase I/II study transplanted human ESCderived RPE in patients with AMD and patients with Stargardt’s macular dystrophy. The
results demonstrated safety and tolerability of the procedure as a primary endpoint [49, 50].
Visual acuity was measured as a secondary endpoint. After six months, four out of the nine
AMD patients and three out of the eight Stargardt’s patient demonstrated improvement in
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visual acuity of 15 letters or more. Although patients on average scored higher on a
subjective quality-of-life after their transplantation, the improvement in vision was modest.
Most recently, retinal transplantation using autologous iPSC-derived RPE was
performed for the first time in a single patient. The patient’s skin fibroblasts were converted
to iPSCs and then differentiated into RPE. Like the study mentioned above, the primary
aim of the iPSC-RPE study was to demonstrate safety of the iPSC-derived cells [51]. The
grafts were well-tolerated with no abnormal growth at the transplant site. Additionally, the
patient’s vision neither improved nor decreased; however, without a comparison to the
control eye, it is difficult to interpret this visual stability.
The next challenge in retinal transplantation clinical trials is to move beyond proofof-concept studies and demonstrate meaningful improvement in vision. To use research
resources effectively, more preclinical work is still needed to explore ways of improving
the efficacy of retinal transplantations. Large animal studies can play a role in filling this
gap of knowledge. Pigs share many characteristics with the human eye; they have similar
sizes and retinal vasculature. Physiologically, the electroretinogram signals are similar
between pig and human eyes, and pig eyes contain a region (the visual streak) analogous
to the human macula, where vision is the most acute [52-54]. Previous studies in the pig
showed survival of transplanted RPC and RPE, with RPCs exhibiting some degree of
integration with the host retina [55-58]. RPCs were able to mature further after
transplantation in the pig retina [58, 59]. In addition, scaffolds were also tested as vehicles
for transplantation in the pig [55, 59]. However, no large animal studies have studied stemcell derived RPCs in a 3-D scaffold model. This project also aimed to test the laminin-521
coated GCH scaffolds in the pig. Further studies in large animals not only will allow
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refinement of transplantation techniques, they can also provide further insight into the
physiology of the retina.
Statement of Purpose
Degenerative retinal disorders are debilitating diseases, for which there are no current
effective treatments to reverse and restore vision. Stem cell based therapies are a possibility
for restoring visual function, and both animal studies and clinical trial yielded promising
results. However, the ongoing challenges are to improve the efficacy and consistency in
differentiation methods and to derive tissue that can significantly restore function. The
purpose of this work is to evaluate the modification of the GCH scaffold with laminin-521
by assessing its ability to support RPC proliferation and differentiation. This project also
transplanted the RPC scaffold model in two animal models, mice and pigs, to assess the
biocompatibility of the scaffold and to evaluate for any therapeutic effects.
Aims
1.   To increase cell attachment and improve RPC differentiation by culturing on
laminin-521 coated GCH (GCH-L521) scaffolds
We hypothesized that laminin-521 coating will results in great numbers of RPC cell
attachment and retention on the scaffold compared to non-coated scaffolds.
Additionally, because laminin-521 is a prominent component of the ILM, the laminin
coated scaffold may provide a differentiation signal and promote further maturation
and polarization of neural retinal cells.
2.   To ameliorate retinal degeneration in RD10 mice, a model of RP, by transplanting
RPC GCH-L521 scaffold grafts
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We hypothesize that the transplanted RPC scaffold graft will slow the degeneration of
photoreceptors in the transplanted eye. Disease pathology will be assessed on histology
and immunofluorescence. Functional recovery will be assessed with multifocal ERG.
3.   To assess tolerability of scaffold culture graft in pig eyes and optimize postsurgical immunosuppression protocol.
We hypothesize that the approved surgical procedure and post-operative
immunosuppression protocol will be sufficient to control post-operative inflammation
and any immune reaction to the scaffold xenograft. Adverse effects of the procedure
will be assessed with daily monitoring. Histology and immunofluorescence will be
used to assess immune reaction at the tissue level. Dosage of prednisone steroids will
be increased if significant amount of inflammatory reactivity is observed.
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METHODS
GCH scaffold synthesis and laminin coating
The planar scaffold was fabricated via a freeze dry process from gelatin (500mg),
chondroitin sulfate (250mg), and hyaluronic acid (500mg) (GCH) dissolved in 10mL of
distilled water [36]. Briefly, gelatin, chondroitin sulfate, and hyaluronic acid were
dissolved in distilled water. The polymers were then crosslinked by adding reagents
glutaraldehyde. The crosslinked solution was transferred into 3cc syringes to yield a
cylindrical shape, frozen for 18hrs at -20°C, and then vacuum dried with a lyophilizer. To
obtain thin circular scaffold disks, the cylindrical GCH monolith was frozen in OCT, and
sectioned with cryotome with 60µm thickness.
I sterilize scaffolds for cell culture by incubating scaffolds in 70% ethanol overnight.
Then scaffolds were washed with PBS three times, then incubated in PBS with 10%
penicillin-streptomycin for 30 min before incubating overnight in NIM. For laminin
coating, GCH scaffolds were placed into individual wells in a 12-well pate without media.
Laminin-521 is gently pipetted onto the scaffold for even coating, and then incubated at
37°C for 30 min.

Differentiation of retinal progenitor cells(RPC)- done by Tina Xia
WA09 human embryonic stem cells were obtained from the Yale Stem Cell Center. WA09
cells were cultured on plates coated with 1% Matrigel and in mTeSR-1 media. Media was
changed every 1-2 days and spontaneously differentiating cells were removed under a
sterile microscope.
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For RPC differentiation, a previously established protocol was used [20]. WA09
cells are incubated with 1U/mL dispase for 30min at 37°C, then blebbstatin is added to the
culture. The cells are then cultured in low-attachment, Lipidure-COAT Plates (Amsbio,
Abingdon, UK) to induce embryoid body (EB) formation. On initial day of differentiation
(D0), EBs were incubated in mTeSR-1. On D1, the EBs were switched to neural induction
media (NIM) in 1:3 dilution with mTeSR-1. The NIM contained Dulbecco’s modified
Eagle’s medium (DMEM) with high glucose, F-12 nutrient medium, 15% knockout serum,
1% N2 supplement, 0.1mM 2-mercaptoethanol, 0.1M nonessential amino acids, 1mM
glutamax, 50U/mL penicillin, and 50µg/mL streptomycin. On D2, EBs were incubated in
NIM was mixed with mTeSR-1 in 1:1 dilution. From days 3 onward, EBs were incubated
with only NIM. At D21, spherical retinal cups containing retinal progenitor cells were
dissected away from the rest of the EB and seeded on GCH scaffolds. NIM was changed 3
times per week.
To assess cell attachment efficiency, ten EBs were seeded onto each sterilized
scaffold, with or without laminin-521 coating. The number of EBs still attached to laminin521 coated or non-coated scaffolds was counted at 48hrs after seeding.

Scaffold degradation assay
Laminin-521 coated and non-coated scaffolds were incubated in PBS at 37°C with solution
change every 3 days. Each week, the scaffold was removed from solution, dried on
absorbent paper and weighed. Scaffolds were tested in triplicates. The data is presented as
percentage of originate weight:
𝑊𝑒𝑖𝑔ℎ𝑡'
×100
𝑊𝑒𝑖𝑔ℎ𝑡(

x -weight at certain week
i -initial weight
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Quantitative real-time RT-PCR
Cellular RNA was extracted using the TRIzol reagent (Qiagen). RPC on GCH scaffold
were sonicated in TRIzol briefly to dissociate the cells and the scaffold before extraction.
1µg of total RNA was used for cDNA synthesis, using iScript Advanced cDNA synthesis
kit (Bio-Rad). iTaqSYBR Green (Bio-Rad) was used for the real-time PCR reaction.
Primer oligos were synthesized at the Keck Biotechnology Resource Laboratory. All
samples were done in triplicates. Relative gene expression was normalized to GAPDH, and
calculated using 2-∆∆Ct.

Immunoblot
Protein was extracted from WA09 cells or RPCs on scaffold by incubating in lysis buffer
with protease inhibitor, 25mM Tris-HCl and 2% SDS. Samples were vortexed and
sonicated to ensure adequate extraction from RPC in the scaffolds, then incubated at room
temperature for 10 min. Samples were then centrifuged for 10 min at 4°C. Equal amount
of protein were loaded into and ran in a 4-20% gradient PAGE gel according to
manufacturer protocol. After transfer on to nitrocellulose paper, the blot was washed with
TBST, blocked with 5% milk, and incubated with primary antibody overnight in 4°C. Then,
the blot was washed again with TBST and incubated with secondary antibody according to
manufacturer protocol. Chemiluminescent reagents were added to the bot and imaged with
the ChemiDoc system (Bio-Rad).
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Immunofluorescence and confocal microscopy
RPC cultures on scaffold were fixed with 4% paraformaldehyde (PFA) for 5min, washed
with PBS, and incubated sequentially in 10% and 30% sucrose for 1 hour each. Then
RPC scaffolds were incubated overnight in 1:1 solution of OCT and 30% sucrose at 4°C.
Then RPC scaffolds were embedded in OCT and cross sectioned with cryotome to 12µm
sections mounted on poly-lysine coated slides. Slides were allowed to dry for 48hrs
before storing in -20°C. For staining, slides were washed 3 times with PBS and
permeabilized for 1hr at room temperature with 0.30% Triton-X100 in PBS. After
washing with PBS, slides were blocked with 10% donkey serum and 0.10% Triton-X100
in PBS for 1hr. Samples were then incubated overnight at 4°C with primary antibodies in
blocking solution, according to manufacturer recommendations on concentration. After
washing with PBS, samples were incubated with secondary chromophore antibodies plus
DAPI for 1 hr. After final PBS wash, slides were mounted for imaging.
For preparing pig tissue slides, fresh harvested eyes were incubated in 4% PFA for
1hr, then the cornea and iris is removed circumferentially and vitreous is carefully removed
with gentle pipetting. The dissected eye is put back in 4% PFA for an additional 1-2 hrs at
4°C. Then eyes are transferred to 10% sucrose for 6hrs, and then to 30% sucrose overnight
in 4°C. Before sectioning, eyes are incubated in a 1:1 mixture of OCT and 30% sucrose for
1 hr. Then, tissue is mounted in OCT, sectioned at 12µm thickness, and mounted on polylysine coated slides.
The migration of RPC on scaffold, with or without laminin-521, was assessed by
DAPI staining to visualize the migration of cell nuclei. RPC differentiation was monitored
by staining for retinal development markers PAX6, RAX, LHX2, CHX10, OTX2, CRX,
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recoverin, BRN3, NEUROD1. For pig samples, TRA-1-85 stain was used to identify
transplanted cells; IL-6 and IBA-1 were used to assess for inflammation and microglia
activation, respectively, from transplantation. An LSM 410 spinning-disc confocal
microscope was used to image the samples.

Histology and hematoxylin and eosin staining
Mice and pig eye tissue was collected, cryopreserved and sectioned onto poly-lysine coated
slides as described above. Slides were stained with hematoxylin and eosin for tissue
structure analysis. Images were captured using the OptraSCAN digital pathology scanner.

RD10 mouse transplantation
Mice experiments were in compliance with and approved by the Yale University
Institutional Animal Care and Use Committee (IACUC). For scaffold transplantation, D21
RPC on GCH scaffold were transplanted subretinally in RD10 mice. On postnatal day 30
(P30), RD10 mice were adequately anesthetized by intraperitoneal injection of ketamine at
100mg/kg. Using small surgical scissors, a small incision is made in the lateral conjunctiva
and sclera of one eye and 1µL of PBS was injected between the choroid and retina to create
a small retinal detachment. A 0.5cm x 0.5cm piece of scaffold with RPC was inserted in
the potential space using forceps. RD10 mice were kept in a dark environment for 1-2 days
after transplantation, then returned to routine animal facility maintenance. Eyes were
harvested at 6 to 10 weeks post-transplantation for tissue analysis.
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Pig optical coherence tomography (OCT) and multi-focal electroretinogram (mfERG)OCT was acquired while animals were under anesthesia either before surgical procedure
or before euthanasia. Two drops of phenylephrine 2.5% and tropicamide 1% each were
applied to the test eye for dilation. A Cirrus HD-OCT 4000 (Zeiss) was used to capture the
OCT, using the Macula Cube 512x128 scan pattern. Animals were positioned up to the
lens, and OCT was scanned when images of good signal can be detected.
For the mfERG, measurements were taken before surgery procedures or before
euthanasia. The surgery or control eye of sedated animals were dilated as described above.
A RETImap machine (Roland Consult, Germany) was used to capture the mfERG. The test
animal was covered with a field shielding blanket to reduce electrical noise artifacts during
measurement. In addition, all unnecessary electronics were shut down during mfERG
recordings. 2.5% hypromellose eye lubricant was applied on a contact lens ERG electrode
and placed on the cornea. Two reference electrodes were placed in the skin of the animal’s
scalp and front leg. The animal, machine, and shielding blanket were grounded. mfERG
measurements were captured according to manufacturer’s protocols. A minimum of 10
cycles were ran per recording to obtain reliable mfERG waveforms.

Pig retinal transplantation
Pig experiments were carried out in compliance with Yale University IACUC regulations
and with approved protocols. Yorkshire breed pigs were used for all transplantation
experiments. Animals were sedated by Yale veterinarian services. 0.2mg/kg of atropine
was given intramuscularly at the time of sedation by veterinarians. Additional drops of
phenylephrine 2.5% and tropicamide 1% were applied to surgical eye. The eye and
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surrounding skin was cleaned with 10% providone-iodine solution and then surgically
draped. A 23G pars plana vitrectomy was done to remove the vitreous. Sterile saline
solution was injected subretinally using a 38G cannula to create a bleb. The retinal incision
site on the bleb was cauterized with diathermy to prevent bleeding. A retinotomy was made
using microscissors along the cauterized retina. The scaffold was placed flatly in the
subretinal space using a specialized inserter device. Fluid-air exchange (FAX) was done to
flatten the transplant site, and air was left in the globe to tamponade the retina. Scleral
incision sites were sutured if needed to prevent gas leakage from the eye. At the completion
of surgery, 1mg of triamcinolone was injected intravitreally and 50mg of cefazolin was
injected under the conjunctiva. (Surgery done by Dr. Ron Adelman and Dr. Scott Ketner,
assisted by Tina Xia)
Animals given a buprenorphine patch for the three days post-operatively and
systemic steroids (prednisone 2mg/kg) every day until end of experiment. Animals were
monitored daily for ocular and systemic symptoms.

Statistical Analysis
Statistical analysis was done using unpaired t-test and one-way ANOVA. Standard error
of measurement (SEM) is indicated in the data figures.
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RESULTS
Laminin-521 was coated onto pre-fabricated gelatin-chondroitin sulfate-hyaluronic acid
(GCH) scaffolds via electrostatic bonding. Therefore, GCH-L521 scaffolds retained the
same porous structure as non-coated GCH scaffolds. To assess whether laminin-521
affected the structural integrity of the polymer scaffold, a simple degradation assay was
done which showed less degradation of the laminin-521 coated scaffold by week 1 and
week 2 compared to non-coated scaffolds. By week 3, there was no significant difference
between the two types of scaffolds (Fig 3). It is noted that there was greater variability in
the weight measurements at three weeks, which may explain the non-significance observed
at that time point.
Figure 3. GCH scaffold
degradation assay. Wet weight was
measured and normalized to initial
scaffold weight. Experiments done
in triplicates, repeated twice.
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Laminin-521 coated GCH scaffold promoted higher cell attachment and migration
on scaffold.
Laminin-521 is the predominant laminin protein found in the ILM, and is thought to play
a role in embryonic retinal development [40, 60]. Therefore, we hypothesize that laminin521 modification of the GCH scaffold may facilitate cell migration into the scaffold matrix.
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As an initial experiment, embryoid bodies (EBs) were seeded onto laminin-521 coated
(GCH-L521) and non-coated scaffolds (GCH) and the percentage of EB attachment after
48 hours was calculated. About 25% more EB cell clusters were attached to laminin-coated
scaffolds compared to non-coated ones (Fig 4A). Cell migration was assessed by imaging
cell nuclei within the scaffold thickness. When retinal cups containing RPCs were seeded
onto GCH-L521, the RPCs populated the pores of the scaffold and migrated through its

A.

100

% EB attachment

entire thickness (Fig 4B, C).

80

p < 0.05

B. En face view

60
40
20
0

Laminin-521 coated

C.

Non-coated

Top of scaffold

60µm

Bottom of scaffold

Figure 4. A) Cell attachment on GCH-L521 scaffold 48 hours after
seeding. ± SEM. B) En face view of RPCs in scaffold. DAPI stains cell
nuclei. C) Cross sectional image of RPC nuclei in GCH-L521. Scaffold
thickness is 60µm.
Laminin-521 GCH scaffold supported the differentiation of RPC
Although cells were able to attach and migrate on the GCH-L521 scaffold, it is essential
that the scaffold also supports continued differentiation of RPC into the different types of
retinal cells. Nine days after seeding on scaffold (total day 30 of differentiation), RPC
continued to express early retinal markers RAX, PAX6, and LHX2. LHX2 is a homeobox
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transcription factor that helps to initiate retinal development from the anterior neural plate
and later mediates Müller cell gliogenesis [61, 62]. RAX is a homeobox gene also involved
in directing early retinal differentiation and retinal stem cell proliferation [63]. PAX6 is an
important master regulator that is actively expressed in RPCs during differentiation [64].
In the D30 cultures, RPC on laminin-521 coated scaffolds expressed LHX2 and PAX6 at
significantly higher levels than RPC on non-coated scaffolds (Figure 5A). Ki67 is a marker
for actively proliferating cells. Although Ki67 expression in both laminin-coated and noncoated cultures decreased compared to early D3 cells, RPC on GCH-L521 had higher Ki67
expression than on non-coated scaffolds, indicating possibly higher cell proliferation on
laminin-coated scaffolds (Figure 5A). By D42 (three weeks after seeding onto scaffold),
retinal differentiation between laminin-coated and non-coated cultures are comparable,
with similar expression of RAX, BRN3 and SIX6. RPC on non-coated GCH scaffolds
expressed higher levels of PAX6, LHX2 and NEUROD1 by D42 (Figure 5B). At this later
time in differentiation, markers of retinal cell specification began to be expressed.
NEUROD1, for example, is a transcription activator that mediates retinal ganglion cell and
amacrine cell differentiation[65], and BRN3 is active in ganglion cell differentiation[66].
Expression of NANOG and OCT4 were monitored to ensure differentiation away
from the pluripotency state. Interestingly, by D30, the expression of NANOG and OCT4
were increased compared to early baseline expression (D3) in both scaffold cultures, most
notably being OCT4 levels. However, by D42 the pluripotency genes decreased in both
cultures, but to a greater degree in the laminin-coated scaffold cultures compared to noncoated scaffold cultures (Figure 5A, B). The unexpected continued expression of NANOG
and OCT4 prompted closer examination of the expression of these genes in the early weeks
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of culture. NANOG expression in both coated and non-coated scaffold cultures increased
above baseline and peaked at D21 and then downregulated, with significantly decreased
expression at D42 (Figure 5C). OCT4 exhibited a similar expression pattern, with initial
upregulation which peaked at D30 and then decreasing expression (Figure 5D). Persistence
of pluripotency genes would be a concern for uncontrolled growth or differentiation.
However, our laminin-coated scaffold cultures demonstrated downregulation of NANOG
and OCT4 by D42 in culture.
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Figure 5. qRT-PCR assay of genes. A) Gene expression at D30 of culture, in L521 coated and non-coated RPC cultures. B) mRNA levels in D42 cultures. C)
Expression of NANOG through 42 days of differentiation. D) Expression of OCT4
with time in differentiation. ± SEM, ****p< 0.0001, **p< 0.01, *p< 0.05
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Assessing gene expression of GCH-L521 RPCs at D61, NANOG and OCT4 were
significantly downregulated at that time, and retinal specifying genes were upregulated to

Fold Expression

indicate appropriate differentiation (Figure 6).

Figure 6. RPC
differentiation at D61 on
GCH-L521. NANOG and
OCT4 were significantly
downregulated. ± SEM
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RPC protein expression of retinal differentiation markers
Immunofluorescence assays were carried out to monitor expression of appropriate retinal
differentiation proteins in RPCs cultured on GCH-L521 scaffold. Figure 7 shows an
example cross-sectional stain of RPCs on the planar scaffold. The scaffold autofluoresces
in each color channel. At D42, RPCs on GCH-L521 expressed the early eye field markers
PAX6 and LHX2, consistent with qRT-PCR data. At lower magnification, one can discern
pockets of RPCs where one gene is expressed greater than the other, i.e. brighter
fluorescence of one marker (Figure 7A). This patterning may indicate active differentiation
of RPCs into the varying types of retinal cells. Further along in culture, RPCs expressed
markers indicative of continued specification of RPCs. CRX and OTX2 are both homeobox
proteins that contribute to photoreceptor differentiation from progenitor cells during
development [67-69]. RPCs on GCH-L521 began expressing CRX and OTX2 by D51.
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D	
  42
A

Figure 7. D42 RPC on
GCH-L521 scaffolds. A) 10x
images; scale bar 50µm.
Homogenous fluorescence is
the autofluorescent scaffold.
B) 40x images; scale bar
20µm. Dotted line
demarcates the bottom edge
of scaffold.

B DAPI

PAX6

Figure 8. D51 RPC on GCH-L521 scaffold. A) photoreceptor differentiation
with CRX, OTX2 and recoverin expression; co-localization of OTX2 and
recoverin. Scale bar, 20µm. B) CHX10 expression, suggesting bipolar cell
specification. Scale bar, 20µm.
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Recoverin, a photoreceptor protein, was also expressed by RPCs and co-localizes with
OTX2 (Figure 7A).
CHX10 is a factor expressed early in retinal development to maintain RPC
proliferation and subsequently mediates bipolar cell differentiation [70, 71]. RPCs on
GCH-L521 expressed CHX10 at D51, suggesting differentiation into retinal interneurons
(Figure 8B). By D77 in culture, additional markers of inner retinal layers were expressed
(Figure 9). HuC/D is a protein expressed in developing ganglions, horizontal and amacrine
cells [72, 73], and BRN3 is a ganglion cell marker [72]. Photoreceptor remain
differentiated as demonstrated by the expression of rhodopsin (Figure 9).

D	
  77
Figure 9. D77 RPC on
GCH-L521 scaffold.
HuC/D indicates
interneuron differentiation.
BRN3 is a ganglion cell
marker. Rhodopsin is a
photoreceptor marker.

Immunoblot assays confirmed the immunofluorescence data of early cell cultures.
In very early D3 cultures, LHX2, PAX6, recoverin and BRN3 were at undetectable levels.
However, all four proteins were upregulated by D71 (Figure 10).

30

LHX2

PAX6

Actin

Actin

Recoverin	
  

BRN3

Actin

Actin

Figure 10. Immunoblot
of retinal differentiation
proteins. Actin blotted
as control.

Segregation of RPC into retinal cell types
Basement membranes are critical parts of tissue structure because they provide cell
adhesion points and regulate cell organization. The ILM has been shown to mediate retinal
lamination and Müller cell organization [37, 74, 75]. Our hypothesis is that the laminin521 coated scaffold, can act effectively as an ILM, and induce self-organization and
lamination of the cultured RPC. In some RPC clusters cultured on GCH-L521, specific cell
types began to segregate, forming gross laminations. Recoverin+ cells (photoreceptor-like
RPCs) segregated from BRN3 (ganglion cell-like RPCs) (Figure 11A). In other clusters,
recoverin+ cells formed distinct layer from LHX2+ cells (likely differentiating Müller cells)
(Figure 11B). It is important to note that such gross lamination was not observed
consistently in every RPC cluster cultured on laminin-coated scaffold.
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Figure 11. Gross RPC laminations observed in some cell clusters. A) BRN3+
cells segregating from recoverin+ cells. Scale bar, 20µm. B) Recoverin+
(green) cells layering next to LHX2+ (magenta) cells. Scale bar, 50µm.
RPC scaffold cultures preserved more nuclei in degenerating photoreceptors
A transplantable tissue ideally will survive and integrate with the host retina to establish
functional connections with host cells. RPCs cultured on laminin-521 coated GCH scaffold
were transplanted into RD10 mice to assess the effect of the graft in a degenerating retina.
The RD10 mouse model contains a mutation in a rod-phosodiesterase gene (PDE6B) that
causes photoreceptor death and subsequent inner retinal degeneration [76, 77]. RD10 mice
provides a model of autosomal recessive retinitis pigmentosa (RP) in humans.
Degeneration begins around three to four weeks after birth with rapid loss of
photoreceptors in the outer nuclear layer (ONL).
After retinal cups containing RPC have differentiated on GCH-L521 scaffold for
three weeks, scaffold cultures were transplanted subretinally in RD10 mice on postnatal
day 30 (P30). Eye tissue was collected ten weeks after transplantation (P100). By that time,
the scaffold appeared to have biodegraded, with no fluorescence evidence on microscopy.
Transplanted RPC survived in the host retina and could be identified with TRA-1-85, a
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marker for human-derived cells (Figure 12). The RPC also stained positive for recoverin
indicating that the transplanted cells maintained their differentiation. As a control, no TRA1-85+ cells were found in the non-transplant eye as expected. By 14 weeks of age (time of
tissue harvest), the ONL of RD10 mice has degenerated to a single layer of photoreceptors
(Figure 12, control). In the transplant eye, more photoreceptor nuclei were present at the
transplant site. The transplanted TRA-1-85+/recoverin+ cells contributed to the ONL
(Figure12, transplant), indicating the ability for the scaffold graft to mitigate the cells loss
in retinal degeneration.

Figure 12. Transplanted RPCs in RD10 mouse retina, identified by TRA-1-85
(human cell marker). Tissue analysis done at 10 weeks post-transplantation.
Recoverin stains for photoreceptors, which compromises the outer nuclear layer
(ONL) of the retina. Arrow heads point to the number cell nuclei in the ONL.

In some regions of the transplant area, transplanted RPCs were observed to have
migrated deeper into the host retina. TRA-1-85+ cells moved into the inner nuclear layer
(INL), where horizontal, amacrine, and bipolar cells are located, and into the inner
plexiform layer (IPL), which is composed of dendrites of ganglion cells (Figure 13). The
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TRA-1-85+ cells that migrated into the inner retina were not recoverin positive, suggesting
that these migrating RPC were likely of another retinal cell lineage than photoreceptors.
IPL
INL
ONL
Graft	
  site
Figure 13. Transplanted RPCs migrating from graft site into the inner retina. 10
weeks post-transplantation. ONL- outer nuclear layer; INL- inner nuclear layer;
IPL- inner plexiform layer. Scale bar, 10µm.

To assess for changes in visual function, multifocal electroretinogram (mfERG)
were measured on the transplanted RD10 mice. ERG measures the electrical signals from
the retina in response to light stimulation. The ERG can be used to monitor retinal
degeneration as signal transduction becomes slower and lower in amplitude [77]. mfERG
is a variation of this testing where electrical activity can be correlated to specific areas of
the retina. We measured the mfERG of RD10 mice before after transplantation to evaluate
for any functional recovery (Figure 14). A characteristic mfERG waveform is shown in
Figure 14B. The N1 peak correlates to photoreceptor activity after a light stimulation, and
the P1 peak correlates to transmission of signal to the bipolar cells in the inner retina.
Proper photoreceptor function is necessary for robust P1 waves. As expected, our data
shows that at time of transplantation (post-natal day 30, P30), P1 amplitude is similar to
wild-type (WT) because degeneration is in the early stages. Four weeks posttransplantation, mfERG was measured again, showing significantly decreased amplitudes
in both the transplanted and non-transplanted eye (Figure 14C). Additionally, there was no
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Figure 14. mfERG of RD10 mice before and after transplantation. A) Idealized
mfERG waveform. Adapted from Dutescu et al. (89) B) Representative fundus
photograph of area of retina where measurements were taken. C) P1 wave amplitude,
values of the measurement area were averaged D) Peak time of P1 wave; values of
measurement area were averaged. Pre-transplant measurement taken at post-natal day
30 (P30). ± SEM
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significant difference between the transplanted eye and the non-transplanted eye. Peak time
is another informative parameter in ERG measurements. It is the time from the onset of
light stimulus to the peak wave amplitude. This time measurement is an indication of the
signal transduction within the retina and can become delayed in retinal disorders when
neuronal connections are disrupted [77, 78]. In our experiment, the peak time was already
delayed at the time of transplantation compared to WT. Repeat measurement four weeks
later did not show significant changes in peak times, in either the transplant or nontransplant eyes (Figure 14D).

Preliminary data on good tolerability of GCH-L521 scaffold in pig eyes
For a retinal graft to be ultimately used in human treatments, it is ideal to conduct
transplantation studies in large animals, whose eyes are more anatomically and
physiologically similar to human eyes. Results from large animal studies can allow further
optimization of retinal grafts. We began a pilot study transplanting RPCs scaffold grafts
into normal pig eyes. The initial aim of the pilot study was to evaluate whether our
immunosuppression protocol was sufficient to control the pig immune reaction against the
RPC xenograft. Data has been collected from eight transplantation procedures so far: four
animals received RPC on GCH-L521 scaffold, one animal received only GCH-L521
scaffold with no cells, another one received only polyester (PET) transwell filter, one
animal received hESC-derived RPE on PET filter, and the last animal received a co-culture
of RPC and RPE. Table 1 provides the details of each animal surgery.
Mild redness and swelling of the conjunctiva was present immediately following
surgical procedures, but typically resolved completely after two days. Subsequently on
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daily monitoring, no animals showed gross signs of ocular inflammation, such as enlarged
blood vessels on the conjunctiva or sclera, hazy cornea, or debris in the anterior chamber.
On histology, mild folding of the retina was observed mainly around the transplantation
region (Figure 15). Additionally, no infiltrating cells or granulomas were present; the
architecture of retinal layers remained fairly intact. To assess immune reactivity at the
tissue level, retina tissue sections were stained for IL-6 and IBA-1. IL-6 is a cytokine that
is highly expressed in inflammation and during graft rejection, and IBA-1 is a marker for
microglia, which can assess for increased immune reactivity [79, 80]. The scaffold was
placed to lay flatly between the retina and the RPE/choroid. I examined the two sides of
the graft on immunofluorescence, one side abutting the retinal ONL and the other abutting
the choroid. There was no significant difference between IL-6 staining between the
transplanted and the non-transplanted control eye, indicating no upregulation of the
inflammatory marker (Figure 16). In the control eye sections, IBA-1 staining identified the
resident microglia cells within the choroid and retina (Figure 16). In transplanted eyes,
IBA-1 positive staining appears mildly increased on the choroid side but not significantly
increased on the retina side compared to control eye. No adjustment of our
immunosuppression protocol was made. In the animals that received RPC on GCH-L521
scaffolds, few TRA-1-85+ cells were found at the transplant site (Figure 17). Compared to
the quantity of RPCs transplanted initially, there was significant cell loss at 22 days after
transplantation.
Complications were observed mainly at the tissue level on dissection (Table 1). As
mentioned above, the most common complications are mild scarring and wrinkling of the
retina around the transplantation site (Figure 15) and vitreous debris. Less common, but
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more serious complications were retinal detachment and lens opacification; both were
most likely caused by inadvertent trauma during the surgical procedure. The two latter
complications prevented imaging and mfERG measurements on follow-up in three
animals.

Figure 15. H&E stain of pig retinal sections. Non-transplant section
shows retinal architecture of the non-operated eye. Transplant site is
where the scaffold was inserted. Transplant adjacent is the areas around
the insertion site, where retinal architecture remained normal.

Figure 16. Few transplanted RPCs (TRA-1-85+) found around the graft
transplantation site. TRA-1-85+ cells were not positive for recoverin. Scale
bar, 20µm.
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Figure 17. Immunoreactivity of scaffold in the host retina. Representative
immunofluorescence sections. Scaffold was inserted flatly between the retina
and choroid. IBA-1 and IL-6 positivity was assessed on both sides of the
scaffold. Recoverin identifies the host photoreceptor layer. Scale bar, 20µm.
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TABLE 1
Animal
332

Scaffold
material
-Transwell

Follow-up
period
Immediate

PET filter

collection

Immunosuppression

Complications

None

N/A

-Triamcinolone (intraocular)

-Gross pathology:

-No cells
344

-GCH

12 days

-No cells

1mg/eye

Posterior lens opacification
Large retinal detachment
Vitreous scarring/traction

358

-GCH-L521

8 days

-D16 EBs

-methylprednisone 2mg/kg IM

- Gross pathology:

(pre-op, once)

Vitreous hemorrhage and

-Triamcinolone (intraocular)

scarring

-Prednisone 2mg/kg PO daily
369

-GCH-L521

15 days

Same as above (#358)

-D71 RPCs

-Gross pathology:
Trace vitreous debris
No major complications

374

-GCH-L521

22 days

Same as above

-No major complications

22 days

Same as above

-Gross pathology:

-D37 RPCs
376

-GCH-L521
-D23 RPCs

Vitreous debris
Mild retinal scarring

382

-hESC-RPE

20 days

Same as above

on PET filter

-Gross pathology:
Posterior lens opacification
Vitreous debris
Retinal scarring

383

Co-culture:
-D56 RPC on
GCH-L521

29 days

Same as above

-Gross pathology:
Mild retinal scarring at
transplant site

-hESC-RPE
on PET filter

Table 1. Summary of pig retinal transplantations. Grafted cells and scaffold, followup length, immunosuppression regimen, and complications are listed. PET- polyester;
IM- intramuscular; PO- per os (by mouth).
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Challenges in pig retinal transplantation
Our preliminary results suggested the immunosuppression was sufficient and the GCHL521 scaffold has good biocompatibility. A secondary goal of the pig project was to
optimize mfERG measurements of pig eyes in order to monitor in visual function after the
surgical procedure. Previous work in the Rizzolo lab conducted mfERG measurements of
pig retina after laser injury and was able to distinguish the light sensitive visual streak from
non-visual streak areas of the retina (YSM Thesis of Laurel Tainsh). We attempted to
measure mfERG before and after intraocular transplantation procedures. The major
challenge was reducing the environmental interference that contributed to the background
artifact of the measurements. The best attempt was made to block interfering
electromagnetic fields: animals were covered with a field shielding blanket, and all
unnecessary electronics were turned off during measurements. However, because we could
not shield the entire surgical room and the sedated animals must continue to be monitored
on the ventilator, the existing artifacts contributed to inconsistent mfERG measurements.
This inconsistency hindered comparison of measurement values from before to after the
transplantation (see Figure 19A).
Another challenge to acquiring consistent and reliable mfERG was the difficulty in
positioning the pig’s eye for imaging. Unlike human subjects who can be instructed to look
in specific directions to image a particular area of the retina, this was not possible in sedated
animals. Occasionally, superficial sutures were put through the sclera of the animal to pull
the eye in desired directions; however, even with manipulation of the animal’s eye, there
could be significant movement during the measurement period, contributing to
unreliability of the recordings. Similarly, on follow-up after transplantation, it was

41

sometimes difficult to position the eye to access the same area of the retina measured on a
previous test. Figure 19B shows an example of good mfERG measurements taken before
and after transplantation in an animal, however, the region of the retina that was measured
did not correspond closely, limiting subsequent comparison.
OCT is a non-invasive imaging modality that captures cross-sectional images
through the retina and allows evaluations of retinal tissue architecture, similar to ultrasound
images. OCT is potentially very useful in retinal transplantation studies because it is a quick
study and can reveal signs of complications without having to collect tissue. Figure 18
shows an example of mild retinal folding at the scaffold transplantation site, but no major
retinal detachments. However, the difficulty with positioning was also a major challenge
in using optical coherence tomography (OCT) to monitor transplanted graft in vivo. It was
difficult to obtain consistent OCT images of the same area in the retina on subsequent
follow-up tests.
Subretinal
thickening: scaffold?
Retinal folds

Retinal folds

Figure 18. Example OCT
images. Changes in retinal
architecture can be imaged,
including retinal folds,
retinal or subretinal thinning
or thickening. Images on
right are the fundus
photograph of the imaged
area. Blue line- where crosssectional image (left) is
located.
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Besides overcoming the technical challenges of large animal studies, the surgical
capacity of the animal facilities is also important in obtaining meaningful data in an
efficient way. This pilot study was the first large animal retinal transplantation study
carried out at Yale University. The Yale Animal Resources Center (YARC) provided the
veterinarian and anesthesia support for the surgical procedures. Veterinarians were also
consulted on the appropriate drugs for pain control and alternative sedation medication to
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optimize mfERG recordings. One main limitation was the low operational capacity of the
animal facility. Due to the time required for mfERG and OCT measurements, one survival
animal procedure can realistically be done in a single day; and commonly one to two
survival procedures can be done in a week, given personnel availability and facility
regulations. The low capacity slowed the optimization process for the surgical procedure
and data collection. Moving forward, increasing the number of procedures per week would
allow experimenters to become even more facile with the transplantation procedure and to
implement timely experimental adjustments as needed.
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DISCUSSION
Retinal degeneration, such as retinitis pigmentosa and AMD, are debilitating disease
causing visual impairment and blindness. Currently, there are no treatments that effectively
reverse disease or can replace dying retinal tissue. The ability to differentiate stem cells
into retinal cells holds promise for developing transplantable grafts that can lead to vision
recovery. More research is investigating the use of scaffolds to culture retinal progenitor
cells (RPCs) for transplantation. The mechanical and physical properties of the scaffold,
such as stiffness, elasticity, and having nanowires or grooves, can be modified to improve
the efficiency of the differentiation process [34, 35]. Another advantage of using scaffolds
is possible higher retention of cells during transplantation. Currently, many transplantation
studies including human clinical trials implant cells by injecting a cell suspension [19, 50,
81] . However, this method leads to significant cell loss, either from reflux of cells during
injection or cell death due to lack of connection with other cells while in suspension. A
scaffold model would not only allow cells to remain adherent but also support synaptic
connections between developing neural retinal cells. Subsequently, the entire composite
graft can be transplanted subretinally.
Previous studies of retinal cultures on scaffold mostly studied RPE cultures, and
scaffolds attempted to mimic the RPE basement membrane composition. Our scaffold
model is unique because it attempts to culture human ESC-derived RPC on a scaffold with
3-dimensional depth. The novel scaffold is synthesized from gelatin, chondroitin sulfate
and hyaluronic acid to closely mimic the compositional ratio of the natural extracellular
matrix (EMC) of the retina [82]. The aim of the culture model was to coerce the RPCs to
use the 3-D structure of the scaffold to self-organize into the natural layers of the retina.
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However, initial results from our lab showed that RPCs did not readily migrate into the
depth of the scaffold; most RPCs remained clustered on top of the scaffold [36]. My project
sought to address this limitation by modifying the scaffold further by coating it with
laminin-521. Existing studies on scaffold cultures coated them with ECM, including
laminin and collagen, to mimic the natural retinal ECM and increase cell adherence [29,
34]. Similarly, we hypothesized that laminin-521 would increase RPC attachment on the
GCH scaffold. Additionally, because laminin-521 is the dominant laminin of the ILM, it
may provide a basement membrane signal and direct tissue organization.
Our data demonstrated that the laminin-521 coated GCH scaffold improved cell
attachment and migration within the scaffold. Higher cell retention in culture increases the
yield of differentiating retinal cells, which enables more experimentations and data
collection. The laminin-521 modification increased cell migration to populate the entire
thickness of the scaffold and is an important first step toward achieving a 3-D selforganizing retinal tissue culture.
Importantly, the RPCs seeded onto GCH-L521 scaffold continued to differentiate
and expressed developmental markers of different interneurons within the retina.
Photoreceptors had begun developing by day 51 in culture, and there was also evidence of
differentiating bipolar cells at that time. By day 77, differentiating ganglion cells began to
appear within the scaffold culture. Interestingly, the pluripotency markers NANOG and
OCT4 were expressed to significant levels into day 30. In other studies, expression of
pluripotency gene decreased earlier in the retinal differentiation process [19, 22]; one study
demonstrated that ESC differentiated into neural phenotype with significant
downregulation of OCT4 by four weeks in culture [19]. The continued expression of
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NANOG and OCT4 may be an effect of the laminin-521 modification. Laminin-521 is
found in abundant levels in the stem cells niche of human ESCs as well [83, 84]. In culture,
the laminin-521 substrate contributes to the maintenance and expansion of ESC, and it is
now commercially available for growing ESC cultures [84]. Therefore, in the context of
the blastocyst in embryonic development, laminin-521 may play a role in maintaining the
pluripotency of ESCs. This property could explain the persistence of NANOG and OCT4
in our cultures during RPC differentiation. Having undifferentiated cells can be a concern
for possible uncontrolled cell growth, however, our results demonstrated that by day 42 in
differentiation media, both pluripotency markers were significantly downregulated, with
continued expression of appropriate retinal markers.
We hypothesized that laminin-521, a component of the ILM, would provide a
developmental signal to promote lamination of RPCs within the scaffold. Gross
laminations were observed in some RPC clusters on the scaffold, where developing
photoreceptors are segregating from the ganglion cell precursors. The RPCs are beginning
to form a composite graft within the scaffold with polarity of the natural retina. For AMD
and retinitis pigmentosa, degeneration begins in the outer retina, in the RPE and
photoreceptor layers, respectively. As disease advances, the inner layers become affected
as well, with remodeling and retraction of neuron processes and death of the inner retina
[77, 85, 86]. To treat advanced retinal diseases, an ideal graft would have the ability to
replace the different types of degenerating cells. Our results indicated an important step
toward achieving this goal.
In the mice transplantation experiments, the RPC scaffold graft demonstrated
biodegradability and continued RPC survival in the host retina. Biodegradability is a useful
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feature of scaffolds because it provides mechanical protection during the culture and
transplantation process but can gradually degrade to allow RPCs to generate their own
ECM and integrate with host cells. At 10 weeks post transplantation in RD10 mice, the
scaffold had degraded and grafted RPC contributed to the native photoreceptor layer.
Structurally, the transplantation was able to replenish the cells lost from degeneration.
Additionally, some RPCs were observed to migrate deeper in the host retina. The migrating
cells were not maturing photoreceptors because they did not express recoverin; therefore
additional retinal markers need to be assayed to identify the migrating cells. It can be
hypothesized that those cells were differentiating into neurons of the inner nuclear layer
and were homing to the appropriate layers of the host retina. We also did not assay for
functional integration of the transplanted RPCs. As a future experiment, tissue sections can
be stained for synaptic proteins, such as α-transducin and PSD-95, to detect any synaptic
integration between grafted and host cells [87, 88].
It is known that photoreceptor loss increases significantly after 1 month of age in
RD10 mice [77]. Therefore, we implanted the GCH-L521 RPC grafts when degeneration
had begun in order to test for any functional recovery from our transplantation. On our
functional testing in the transplanted RD10 mice, the mfERG did not show an effect from
the implantation. Additional work, both in graft culture and functional testing, needs to be
done to achieve the goal of demonstrating functional visual recovery. mfERG is a relatively
new method for measuring retinal function in rodent studies. More commonly, a full-field
ERG is used to assess visual function, which calculates a summary electrical signal from
the entire stimulated area. mfERG divides the stimulated area into smaller segments and
measure the retinal signal, so that signal waveforms can be correlated to specific stimulated
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areas (Figure 19). This feature is useful for evaluating the efficacy of transplantation
because the implantation area is relatively small within the whole retina. Therefore,
mfERG would be able to discern changes in retinal function specifically at the transplant
site, which may not be discernable if full-field ERG were used. However, a trade-off to
having geographic specificity is that the measured signals are weaker, which often requires
recordings over several minutes. The parameters for applying mfERG to mice is still being
optimized, such as stimulus frequency and intensity, and landmarks for visualization [89].
To improve on our RD10 mouse mfERG measurements, mfERG monitoring can start
earlier and more frequently to detect any small effects of the procedure. One technical
change that may improve mfERG measurements and reduce background noise is to record
ERG signals for up to 10 minutes [89]. Additionally, new instrument hardware is available
that can provide higher intensity of the stimulation light, which may improve the retinal
response and the mfERG signals.
To move research toward human treatments, large animal studies can lead to further
optimization of therapeutic methods because of increased anatomical and physiologic
similarity to human tissues. Previous studies of retinal transplantation in pigs implanted
RPE cells or RPCs that were in suspension, with good tolerability, graft survival and
possible integration of transplanted cell within the host [56-58, 90]. Our pilot study tested
the feasibility of transplanting a 3-D RPC scaffold graft and controlling the adverse effects
of the procedure. The preliminary data indicated good tolerability of the graft with no
significant difference in immune reaction between the transplanted and non-transplanted
eye. Our immunosuppression protocol, one dose of prednisone a week before surgery and
daily prednisone (2mg/kg) after surgery, was sufficient to control any inflammatory and
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immune processes. Immunosuppression was needed in our study because we transplanted
cells derived from human ESC. Our implanted cells did have limited migration into the
host retina. However, this may be due to the short follow-up period for tissue analysis; our
experiments did not go past four weeks post-transplantation. At that time, the scaffold had
not degraded in the subretinal space, and may be limiting the interaction between grafted
and host cells.
As discussed in the results section, the pig transplantation study encountered
several technical challenges. The complications associated with surgery was expected as
part of the learning curve of a large animal study, and were quickly minimized with
increased experience. However, obtaining consistent and valid measurements on mfERG
and OCT were larger challenges to overcome. Additional methods of reducing signal
artifacts need to be tested to gain reliable mfERG readings. For example, more extensive
electromagnetic shielding of the operating room may be required to reduce background
noise [91]. Also obtaining mfERG immediately after anesthesia of the animal may also
improve quality of measurements [91].
The long-term goal of this project is to develop a viable retinal graft capable of
restoring visual function. An ideal graft would include all the cell types lost in the
degenerative process. With our initial success in culturing RPC on a 3-D scaffold, our lab
is exploring the effects of co-culturing the RPC scaffold culture with a RPE monolayer.
Reciprocal interaction between RPE and developing RPCs may facilitate further
maturation of retinal cells than monoculture alone. Bruch’s membrane, the basement
membrane on the basal side of RPE cells, has also been shown to play a role in retinal
development. In the developing chick retina, Bruch’s membrane promotes proper
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polarization of membrane proteins in RPE cells [92]. Indeed, flat polymer scaffolds have
been synthesized to mimic Bruch’s membrane to better culture RPE cells [93-95]. As a
future direction, we can consider co-culturing our 3-D RPC scaffold graft with RPE
monolayers cultured on synthetic Bruch’s membrane, to form a graft that mimics native
retina even more closely. Additionally, the ability to generate tissue similar to native retina
in culture offers the possibility for more effective pharmacologic testing ex vivo before
moving to animal studies.
Overall, this project demonstrated that a novel laminin-521 coated porous scaffold
can support growth and differentiation of ESC-derived RPCs. RPC GCH-L521 grafts were
able to survive in the subretinal space of RD10 mice and exhibited some degree of
migration within the host retina. These scaffold cultures can also be translated into studies
in larger animals, demonstrating good tolerability of such a 3-D RPC scaffold graft.
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